000538 云南白药
已收盘 09-02 15:00:00
资讯
新帖
简况
云南白药上半年营收218.84亿元 拟现金分红18.52亿元
经济参考网 · 09-02 20:35
云南白药上半年营收218.84亿元 拟现金分红18.52亿元
诚通证券：给予云南白药增持评级
证券之星 · 08-31 19:05
诚通证券：给予云南白药增持评级
云南白药（000538）披露2026年第一次临时股东会通知，8月31日股价上涨0.78%
证券之星 · 08-31 17:59
云南白药（000538）披露2026年第一次临时股东会通知，8月31日股价上涨0.78%
股市必读：云南白药中报 - 第二季度单季净利润同比下降2.03%
证券之星 · 08-31 06:06
股市必读：云南白药中报 - 第二季度单季净利润同比下降2.03%
云南白药(000538)6月30日股东户数18.94万户，较上期增加11.87%
证券之星 · 08-29
云南白药(000538)6月30日股东户数18.94万户，较上期增加11.87%
图解云南白药中报：第二季度单季净利润同比下降2.03%
证券之星 · 08-29
图解云南白药中报：第二季度单季净利润同比下降2.03%
云南白药：2026年上半年净利润37.01亿元，同比增长1.88%
格隆汇 · 08-28
云南白药：2026年上半年净利润37.01亿元，同比增长1.88%
两融余额重获连增、半月增超730亿，市场回暖信号渐强？
第一财经 · 08-16
两融余额重获连增、半月增超730亿，市场回暖信号渐强？
2026西普会聚焦药店转型：从“卖药”到“健康驿站”的业态重构
智通财经 · 08-13
2026西普会聚焦药店转型：从“卖药”到“健康驿站”的业态重构
【私募调研记录】红筹投资调研云南白药
证券之星 · 08-12
【私募调研记录】红筹投资调研云南白药
【私募调研记录】盘京投资调研西部矿业、云南白药
证券之星 · 08-12
【私募调研记录】盘京投资调研西部矿业、云南白药
云南白药：8月11日接受机构调研，包括知名机构盘京投资的多家机构参与
证券之星 · 08-11
云南白药：8月11日接受机构调研，包括知名机构盘京投资的多家机构参与
云南白药：健康品事业群在未来发展中，将继续发挥品牌全渠道的协同能力
证券日报网 · 08-11
云南白药：健康品事业群在未来发展中，将继续发挥品牌全渠道的协同能力
云南白药：2025年，云南白药气雾剂和膏贴等核心系列产品销售收入总额超过55亿元
证券日报网 · 08-11
云南白药：2025年，云南白药气雾剂和膏贴等核心系列产品销售收入总额超过55亿元
股市必读：云南白药（000538）8月7日董秘有最新回复
证券之星 · 08-10
股市必读：云南白药（000538）8月7日董秘有最新回复
云南白药：气血康口服液改善心脏和血管健康的临床研究项目论文已在《转化内科学杂志》发表
证券之星 · 08-07
云南白药：气血康口服液改善心脏和血管健康的临床研究项目论文已在《转化内科学杂志》发表
云南白药：持续夯实内在价值，多措并举提升股东回报
证券之星 · 08-07
云南白药：持续夯实内在价值，多措并举提升股东回报
云南白药：经营业绩逆势增长
证券之星 · 08-07
云南白药：经营业绩逆势增长
云南白药获得发明专利授权：“一种多孔二氧化硅及其应用”
证券之星 · 08-05
云南白药获得发明专利授权：“一种多孔二氧化硅及其应用”
研报掘金丨财信证券：首予云南白药“增持”评级，加快培育第二增长曲线
格隆汇 · 07-28
研报掘金丨财信证券：首予云南白药“增持”评级，加快培育第二增长曲线
加载更多
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":50.6,"timestamp":1788332613000,"preClose":50.68,"halted":0,"volume":5705394,"delay":0,"changeRate":-0.0016,"floatShares":1784000000,"shares":1784000000,"eps":2.9266,"marketStatus":"已收盘","change":-0.08,"latestTime":"09-02 15:00:00","open":50.68,"high":50.85,"low":50.47,"amount":289000000,"amplitude":0.0075,"askPrice":50.61,"askSize":34,"bidPrice":50.6,"bidSize":176,"shortable":0,"etf":0,"ttmEps":2.9266,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":5,"adr":0,"adjPreClose":50.68,"symbolType":"stock","openAndCloseTimeList":[[1788312600000,1788319800000],[1788325200000,1788332400000]],"highLimit":55.75,"lowLimit":45.61,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.21,"roa":"--","peRate":17.289688,"roe":"9.04%","epsLYR":2.89,"committee":0.318519,"marketValue":90284000000,"turnoverRate":0.0032,"status":1,"floatMarketCap":90277000000},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2664814770","title":"云南白药上半年营收218.84亿元 拟现金分红18.52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814770","media":"经济参考网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664814770?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:35","pubTimestamp":1788352500,"startTime":"0","endTime":"0","summary":"上半年，公司实现营收218.84亿元，同比增长2.95%；归母净利润37.01亿元，同比增长1.88%，营收与利润保持双增。公司同时公告，拟实施2026年特别分红，现金分红总额18.52亿元。其中，云南白药气雾剂销售收入超15亿元，云南白药膏销售收入超7亿元。云南白药2026年半年报首次披露了聚药堂业绩情况，上半年，聚药堂实现主营业务收入3.18亿元，完成率为51.68%；实现净利润2236.71万元，完成率为37.47%。本次收购前，聚药堂2024年实现营收6.32亿元，净利润6932.83万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-02/doc-iniqmwqq4603531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VIG","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077962","title":"诚通证券：给予云南白药增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077962?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:05","pubTimestamp":1788174343,"startTime":"0","endTime":"0","summary":"诚通证券股份有限公司李志新近期对云南白药进行研究并发布了研究报告《2026年中报业绩点评：整体营收利润双增，二线大单品持续突破》，给予云南白药增持评级。 云南白药 事件： 公司发布2026年中期报告，期内营收利润同比双增。本文数据来源于诚通证券股份有限公司，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100030102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607124","title":"云南白药（000538）披露2026年第一次临时股东会通知，8月31日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663607124?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:59","pubTimestamp":1788170342,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，云南白药报收于50.39元，较前一交易日上涨0.78%，最新总市值为899.09亿元。该股当日开盘50.51元，最高50.58元，最低50.0元，成交额达5.37亿元，换手率为0.6%。近日，云南白药集团股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年9月15日召开2026年第一次临时股东会，会议由第十一届董事会召集，现场会议地点为昆明市呈贡区云南白药街3686号公司白药空间二楼会议室。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100025634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1993786604.SGD","LU1960683339.HKD","BK0187","BK0196","BK0188","BK0012","BK0239","LU1807302812.USD","BK0175","000538","BK0164","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663904729","title":"股市必读：云南白药中报 - 第二季度单季净利润同比下降2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663904729","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663904729?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:06","pubTimestamp":1788127587,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告2026年中报显示，上半年度公司主营收入218.84亿元，同比上升2.95%；归母净利润37.01亿元，同比上升1.88%；扣非净利润35.18亿元，同比上升1.66%；其中2026年第二季度，公司单季度主营收入102.81亿元，同比下降1.29%；单季度归母净利润16.64亿元，同比下降2.03%；单季度扣非净利润15.53亿元，同比下降1.29%；负债率25.56%，投资收益6.02亿元，财务费用1817.5万元，毛利率30.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012619","title":"云南白药(000538)6月30日股东户数18.94万户，较上期增加11.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012619","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012619?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:11","pubTimestamp":1787994719,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药披露，截至2026年6月30日公司股东户数为18.94万户，较3月31日增加2.01万户，增幅为11.87%。在中药行业个股中，云南白药股东户数高于行业平均水平，截至6月30日，中药行业平均股东户数为5.16万户。从股价来看，2026年3月31日至2026年6月30日，云南白药区间跌幅为11.08%，在此期间股东户数增加2.01万户，增幅为11.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","LU1807302812.USD","BK0028","BK0196","BK0012","BK0239","LU1993786604.SGD","BK0188","BK0175","000538","BK0187","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013399","title":"图解云南白药中报：第二季度单季净利润同比下降2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013399","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663013399?lang=zh_cn&edition=full","pubTime":"2026-08-29 03:32","pubTimestamp":1787945520,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药2026年中报显示，上半年度公司主营收入218.84亿元，同比上升2.95%；归母净利润37.01亿元，同比上升1.88%；扣非净利润35.18亿元，同比上升1.66%；其中2026年第二季度，公司单季度主营收入102.81亿元，同比下降1.29%；单季度归母净利润16.64亿元，同比下降2.03%；单季度扣非净利润15.53亿元，同比下降1.29%；负债率25.56%，投资收益6.02亿元，财务费用1817.5万元，毛利率30.06%。财报数据概要请见下图:本文数据来源于云南白药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900007462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729064","title":"云南白药：2026年上半年净利润37.01亿元，同比增长1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729064","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662729064?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:55","pubTimestamp":1787914538,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0196","BK0175","LU1807302812.USD","000538","BK0239","BK0164","BK0012","LU1960683339.HKD","BK0188","BK0187","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659917216","title":"两融余额重获连增、半月增超730亿，市场回暖信号渐强？","url":"https://stock-news.laohu8.com/highlight/detail?id=2659917216","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659917216?lang=zh_cn&edition=full","pubTime":"2026-08-16 19:30","pubTimestamp":1786879859,"startTime":"0","endTime":"0","summary":"两融余额连续增加，杠杆资金逐渐回流，A股的阶段性“去杠杆”是否已完成？Wind统计显示，8月4日至13日，两融余额已连续8个交易日增加，截至13日两融规模为2.68万亿元，较月初增加约730亿元。7月初至当月中旬，两融余额一度出现13连降，其间总规模减少超3000亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608163842526722.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608163842526722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["82846","601318","LU0890818403.SGD","02846","688256","BK0201","LU1328277881.USD","603986","83130","IE00B12V2V27.USD","IE0003795394.USD","IE00B031HY20.USD","399300","600276","HK0000306701.USD","BK0207","LU0231483743.USD","159982","IE00BZ08YR35.GBP","VGT","LU1880383366.USD","LU0264606111.USD","000538","LU1969619763.USD","LU1719994722.HKD","300476","BK0060","83188","LU0039217434.USD","IE0032431581.USD","BK0125","000651","IE00BKZH1Z71.USD","03130","07233","300308","02827","600183","LU0348735423.USD","000333","LU1130305938.SGD","301717","301308","LU2008162690.USD","LU0405327494.USD","000895","BK0028","LU1880383440.USD","03188","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152531","title":"2026西普会聚焦药店转型：从“卖药”到“健康驿站”的业态重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152531","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659152531?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:35","pubTimestamp":1786624548,"startTime":"0","endTime":"0","summary":"今年1月，商务部等九部委发布《关于促进药品零售高质量发展的意见》，首次在全国层面推动药店从“药品销售终端”升级为”健康驿站”，强化专业服务、健康促进与应急保障三大核心功能。事实上，讨论至最后，与会嘉宾一致认为，健康驿站是行业唯一确定的转型方向，但绝非一蹴而就。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","SG9999001176.SGD","SG9999002224.SGD","BK4534","LU0058720904.USD","LU1066051498.USD","LU1066053197.SGD","000423","000538","BK4592","IE00B3T34201.USD","LU1894683264.USD","LU1057294990.SGD","LU0122379950.USD","LU0321505439.SGD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU2596442595.SGD","PFE","LU1960683339.HKD","SGXZ57979304.SGD","LU1023059063.AUD","BK4550","002727","BK0164","OZEM","BK0187","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0456855351.SGD","301017","IE00BLSP4452.SGD","BK4599","BK0239","BK0012","IE00BBT3K403.USD","BK0196","LU0985481810.HKD","IE00BLSP4239.USD","SG9999004220.SGD","BK4568","BK0183","BK4581","BK0209","SG9999001176.USD","SG9999003800.SGD","LU0868494617.USD","SG9999013999.USD","BK4588","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658358944","title":"【私募调研记录】红筹投资调研云南白药","url":"https://stock-news.laohu8.com/highlight/detail?id=2658358944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658358944?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:13","pubTimestamp":1786493623,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月11日披露的机构调研信息，知名私募红筹投资近期对1家上市公司进行了调研，相关名单如下：1）云南白药 调研纪要：公司致力于打造具备持续生命力的核心产品，构建“大单品体系”，药品板块包括云南白药核心系列、气血康口服液等14个单品，健康品聚焦养元青洗护及抗敏、美白、儿童牙膏等高潜力赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081200006643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0239","LU1993786604.SGD","LU1960683339.HKD","000538","BK0028","BK0188","BK0175","BK0196","LU1807302812.USD","BK0012","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658944381","title":"【私募调研记录】盘京投资调研西部矿业、云南白药","url":"https://stock-news.laohu8.com/highlight/detail?id=2658944381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658944381?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:13","pubTimestamp":1786493622,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月11日披露的机构调研信息，知名私募盘京投资近期对2家上市公司进行了调研，相关名单如下：1）西部矿业 调研纪要：西藏自治区税务局于2026年7月28日发布资源税调增公开征求意见通知，拟将选矿铜资源税税率由5.0%上调至9.0%，原矿铜税率由7.0%上调至10.0%，目前方案处于征求意见阶段，截止至2026年8月27日，最终执行标准尚存不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081200006642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0155","601168","BK0175","000538","LU1807302812.USD","BK0239","LU1934453819.USD","BK0164","BK0012","LU1979443071.USD","BK0242","LU1960683339.HKD","BK0188","BK0187","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919512","title":"云南白药：8月11日接受机构调研，包括知名机构盘京投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658919512?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:32","pubTimestamp":1786458755,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月11日云南白药发布公告称公司于2026年8月11日接受机构调研，中金公司朱言音、盘京投资曹姗姗、深圳红筹投资王之栋、平安基金陶然、博时基金杨涛参与。云南白药2026年一季报显示，一季度公司主营收入116.03亿元，同比上升7.02%；归母净利润20.37亿元，同比上升5.31%；扣非净利润19.65亿元，同比上升4.12%；负债率25.31%，投资收益2.43亿元，财务费用1138.96万元，毛利率30.63%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","LU1960683339.HKD","000538","BK0012","BK0164","BK0187","LU1807302812.USD","LU1993786604.SGD","BK0175","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919320","title":"云南白药：健康品事业群在未来发展中，将继续发挥品牌全渠道的协同能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919320","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658919320?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:32","pubTimestamp":1786455120,"startTime":"0","endTime":"0","summary":"证券日报网8月11日讯，云南白药在接受调研时表示，2025年，健康品事业群在保持线下渠道竞争优势的同时，通过场景化营销、功效科普种草、短直联动转化等方式，在内容电商、货架电商、即时零售领域发力，带动线上销售同比增长27%。健康品事业群在未来发展中，将继续发挥品牌全渠道的协同能力，通过分渠道分产品精细化运营，针对即时零售、内容电商、仓储会员店等增量渠道保持高度关注，坚持大胆试新、小步快跑的模式寻找增量，同时也通过研发创新，加速产学研平台的产品转化，积极培育新的增长点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-11/doc-inimyhkh5705366.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-11/doc-inimyhkh5705366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1807302812.USD","BK0164","BK0187","BK0028","BK0012","BK0239","LU1993786604.SGD","BK0188","000538","LU1960683339.HKD","BK0196","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658376919","title":"云南白药：2025年，云南白药气雾剂和膏贴等核心系列产品销售收入总额超过55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658376919","media":"证券日报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658376919?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:32","pubTimestamp":1786455120,"startTime":"0","endTime":"0","summary":"证券日报网8月11日讯，云南白药在接受调研时表示，2025年，云南白药气雾剂和膏贴等核心系列产品销售收入总额超过55亿元，较去年同期增长超18%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-11/doc-inimyhkh5705370.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-11/doc-inimyhkh5705370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0187","BK0239","BK0188","BK0175","000538","LU1993786604.SGD","LU1807302812.USD","BK0028","BK0012","LU1960683339.HKD","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658576608","title":"股市必读：云南白药（000538）8月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658576608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658576608?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:41","pubTimestamp":1786300870,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，云南白药报收于50.76元，上涨0.14%，换手率0.53%，成交量9.47万手，成交额4.79亿元。股价以长期低迷恳请管理层重视。目前，以云南白药自有基地认证品种共有3个，分别为重楼、当归、红花，面积达898亩，合作共建GAP基地面积3695亩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000538","LU1993786604.SGD","BK0196","LU1960683339.HKD","BK0188","BK0164","BK0175","BK0187","LU1807302812.USD","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657611197","title":"云南白药：气血康口服液改善心脏和血管健康的临床研究项目论文已在《转化内科学杂志》发表","url":"https://stock-news.laohu8.com/highlight/detail?id=2657611197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657611197?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:36","pubTimestamp":1786095368,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药08月07日在投资者关系平台上答复投资者关心的问题。有三个问题：1，气血康作为OTC产品，什么时候可以在广告营销上加上改善血管健康方面的内容？2，最近大火的张雪曾在访谈中提到涂了云南白药效果很好。3，最近董路率领的足球小将取得了成功。气血康口服液改善心脏和血管健康的临床研究项目论文《Effectiveness and safety of Qixuekang Oral Liquid on vascular health》已在《转化内科学杂志》发表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700029998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1993786604.SGD","LU1960683339.HKD","BK0187","BK0196","BK0188","BK0012","BK0239","LU1807302812.USD","BK0175","000538","BK0164","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657611515","title":"云南白药：持续夯实内在价值，多措并举提升股东回报","url":"https://stock-news.laohu8.com/highlight/detail?id=2657611515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657611515?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:33","pubTimestamp":1786095192,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药08月07日在投资者关系平台上答复投资者关心的问题。云南白药长期投资价值突出，当前股价波动主要受宏观市场环境、市场资金偏好等外部因素影响，存在一定不确定性。公司高度重视市值管理工作，持续夯实内在价值，保持战略定力，强化业务聚焦，寻求系统突破，卓越运营管理，构建共赢格局，多措并举提升股东回报，以切实的经营成果回馈广大投资者，提升投资者获得感。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700029834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0164","BK0175","000538","LU1993786604.SGD","BK0196","LU1960683339.HKD","BK0188","BK0239","LU1807302812.USD","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657061155","title":"云南白药：经营业绩逆势增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2657061155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657061155?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:33","pubTimestamp":1786095187,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药08月07日在投资者关系平台上答复投资者关心的问题。公司有足够的现金，为何在股价这么低的时候不采取回购的措施，是对公司的发展没有信心吗云南白药回复：您好！云南白药长期投资价值突出，当前股价波动主要受宏观市场环境、市场资金偏好等外部因素影响，存在一定不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700029824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1960683339.HKD","BK0188","BK0187","BK0196","BK0175","BK0164","LU1807302812.USD","BK0012","LU1993786604.SGD","000538","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657696395","title":"云南白药获得发明专利授权：“一种多孔二氧化硅及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2657696395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657696395?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:52","pubTimestamp":1785873178,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示云南白药新获得一项发明专利授权，专利名为“一种多孔二氧化硅及其应用”，专利申请号为CN202410625618.0，授权日为2026年8月4日。今年以来云南白药新获得专利授权16个，较去年同期减少了15.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500005929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","000538","BK0196","BK0012","BK0164","BK0187","LU1960683339.HKD","BK0188","BK0175","LU1807302812.USD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654073028","title":"研报掘金丨财信证券：首予云南白药“增持”评级，加快培育第二增长曲线","url":"https://stock-news.laohu8.com/highlight/detail?id=2654073028","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654073028?lang=zh_cn&edition=full","pubTime":"2026-07-28 13:44","pubTimestamp":1785217445,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1807302812.USD","BK0164","LU1993786604.SGD","161027","BK0012","BK0239","LU1960683339.HKD","BK0028","BK0196","BK0187","BK0175","BK0188","000538"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788378740496,"stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0323},{"period":"3month","weight":0.0412},{"period":"6month","weight":-0.072},{"period":"1year","weight":-0.1114},{"period":"ytd","weight":-0.082}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":0.0346},{"period":"3month","weight":-0.0287},{"period":"6month","weight":-0.0443},{"period":"1year","weight":0.0216},{"period":"ytd","weight":-0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"189362人(较上一季度增加11.87%)","perCapita":"9421股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}